Indications and limitations of vismodegib for basal cell carcinoma--reply

Saved in:
Bibliographic Details
Published inJAMA ophthalmology Vol. 132; no. 7; p. 906
Main Authors Gill, Harmeet S, Moscato, Eve E, Silkiss, Rona Z
Format Journal Article
LanguageEnglish
Published United States 01.07.2014
Subjects
Anilides - therapeutic use
Antineoplastic Agents - therapeutic use
Carcinoma, Basal Cell - drug therapy
Eyelid Neoplasms - drug therapy
Female
Humans
Male
Orbital Neoplasms - drug therapy
Pyridines - therapeutic use
Skin Neoplasms - drug therapy
Online AccessGet more information

Cover

More Information
ISSN:2168-6173
DOI:10.1001/jamaophthalmol.2014.1805